← All trials
NCT00465855
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 3, 2007
- Primary completion
- Sep 10, 2016
- Completion date
- Jan 28, 2017
- First posted
- Apr 25, 2007
- Last posted
- Feb 12, 2021
- Enrollment
- 75
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Allegiance HealthLead sponsor
- Deseret FoundationCollaborator
- Allegiance HealthOverall official - principal investigator
- Allegiance HealthOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.